Skip to Content
U.S. National Institutes of Health
Last Updated: 03/05/10

Strategy Group Meeting Agenda

Bethesda Marriott

May 26, 2005

8:00 a.m. Registration and Light Refreshments
8:30 a.m. Introductions
Sheila Taube, Ph.D., National Cancer Institute
8:45 a.m. Embedding and Evaluating Endpoints in Prostate Cancer Trials

Prostate 101+: Disease States, Treatment Issues, and the Use of PSA Endpoints
Derek Raghaven, M.D., Ph.D., Cleveland Clinic Taussing Cancer Center

Endpoint Definitions
Lisa McShane, Ph.D., National Cancer Institute

Overview of FDA Workshops and Issues
Donna Griebel, M.D., U.S. Food and Drug Administration

Review of NCI Trials:  Opportunities for Endpoint Studies
Alison Martin, M.D., National Cancer Institute

11:00 a.m.Discussion
12:30 p.m.Lunch
1:15 p.m.NCI Updates
1:45 p.m.TAILORx (PACCT-1) Trial
2:15 p.m.Colon Studies Update
2:45 p.m.Lung Studies Update
3:15 p.m.Adjourn